Influence of Postoperative Treatment on Survival in Patients with Uterine Papillary Serous Carcinoma

By Bancher-Todesca D.   Neunteufel W.   Williams K.E.   Prainsack D.   Breitenecker G.   Friedlander M.L.   Hacker N.F.  

Gynecologic Oncology, Vol. 71, Iss. 3, 1998-12 ,pp. : 344-347

Elsevier

Access to resources Recommend Favorite

Amplification of the bromodomain-containing protein 4 gene in ovarian highgrade serous carcinoma is associated with worse prognosis and survival

By    

Molecular and Clinical Oncology, Vol. 3, Iss. 6, 2015-01 ,pp. : 1291-1294

Science Publishers

Access to resources Recommend Favorite

Expression of CD44 in effusions of patients diagnosed with serous ovarian carcinoma – diagnostic and prognostic implications

By Berner Heidi   Davidson Ben   Berner Aasmund   Risberg Bjørn   Kristensen Gunnar   Trope Claes   Van de Putte Gregg   Nesland Jahn  

Clinical and Experimental Metastasis, Vol. 18, Iss. 2, 2000-03 ,pp. : 197-202

Springer Publishing Company

Access to resources Recommend Favorite

Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with highgrade serous ovarian carcinoma

By          

Oncology Letters, Vol. 8, Iss. 4, 2014-01 ,pp. : 1652-1656

Spandidos Publications

Access to resources Recommend Favorite

TP53 oncomorphic mutations predict resistance to platinum and taxanebased standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma

By  

International Journal of Oncology, Vol. 46, Iss. 2, 2015-01 ,pp. : 607-618

Spandidos Publications

Access to resources Recommend Favorite